Harvard Bioscience 10K Form

Sell

21

HBIO
Harvard Bioscience

Last Price:

$0.65

Seasonality Move:

-0.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-11-07	10Q	HBIO/Harvard Bioscience Quarterly
2023-08-08	10Q	HBIO/Harvard Bioscience Quarterly
2023-04-26	10Q	HBIO/Harvard Bioscience Quarterly
2022-11-09	10Q	HBIO/Harvard Bioscience Quarterly
2022-08-04	10Q	HBIO/Harvard Bioscience Quarterly

Receive HBIO News And Ratings

See the #1 stock for the next 7 days that we like better than HBIO

HBIO Financial Statistics

Sales & Book Value

Annual Sales:	$94.1M
Cash Flow:	$1.3M
Price / Cash Flow:	185.32
Annual Sales:	$1.44
Price / Book:	0.48

Profitability

EPS (TTM):	-0.29000
Net Income (TTM):	$-12.4M
Gross Margin:	$54.8M
Return on Equity:	-18.36%
Return on Assets:	-9.44%

Harvard Bioscience Earnings Forecast

Key Harvard Bioscience Financial Ratios

The Gross Profit Margin over the past 27 years for HBIO is 58.18%.
The Selling, General & Administrative Expenses for HBIO have been equal to 46.43% of Gross Profit Margin.
The Research & Development expenses have been 11.05% of Revenue.
The Net Earning history of HBIO is -13.18% of Total Revenues.
Per Share Earnings over the last 27 years have been positive in 13 years.

Harvard Bioscience Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Life Sciences Tools & Services
Sector:	Health Care
Current Symbol:	HBIO
CUSIP:	416906
Website:	harvardbioscience.com

Debt

Debt-to-Equity Ratio:	0.58
Current Ratio:	0.82
Quick Ratio:	0.35

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	5.3

HBIO Technical Analysis vs Fundamental Analysis

Sell

21

Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy or a Sell?

Harvard Bioscience stock is rated a Sell

The current Harvard Bioscience [HBIO] share price is $0.69. The Score for HBIO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.